Efficacy and safety of delapril (cas 110508-92-4) plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial
-
Add time:08/17/2019 Source:sciencedirect.com
Background:The use of coombination therapy is required to achieve blood pressure targets in 40% to 75% of patients with hypertension. There have been few studies comparing the efficacy and tolerability of the new fixed combination of the angiotensin-converting enzyme (ACE) inhibitor delapril (cas 110508-92-4) 30 mg and the calcium channel antagonist manidipine 10 mg with those of a standard combination of another ACE inhibitor and a diuretic.
We also recommend Trading Suppliers and Manufacturers of delapril (cas 110508-92-4). Pls Click Website Link as below: cas 110508-92-4 suppliers
Prev:Effect on the development of ankle edema of adding delapril (cas 110508-92-4) to manidipine in patients with mild to moderate essential hypertension: A three-way crossover study
Next:Effects of the fixed combination of manidipine plus delapril (cas 110508-92-4) in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Safety and efficacy study of delapril (cas 110508-92-4) versus enalapril in patients with congestive heart failure08/22/2019
- Congestive heart failure in elderly patients: Controlled study of delapril (cas 110508-92-4) versus captopril08/21/2019
- delapril (cas 110508-92-4) slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits08/20/2019
- delapril (cas 110508-92-4) versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy08/19/2019
- Effects of the fixed combination of manidipine plus delapril (cas 110508-92-4) in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial08/18/2019
- Effect on the development of ankle edema of adding delapril (cas 110508-92-4) to manidipine in patients with mild to moderate essential hypertension: A three-way crossover study08/16/2019
- Rationale for use of the fixed combination of delapril (cas 110508-92-4) and manidipine in the treatment of hypertension in patients with diabetes mellitus08/15/2019
- delapril (cas 110508-92-4) versus enalapril in patients with congestive heart failure08/14/2019
- Original ArticleDissolution method for delapril (cas 110508-92-4) and manidipine combination tablets based on an absorption profile of manidipine☆08/13/2019